Evidence (8/10): Based on a legitimate peer-reviewed study in Nature Neuroscience with a full citation and DOI. The Sox9-MEGF10-phagocytosis mechanism is accurately described and the experimental design is fairly represented, including the important detail that mice already had cognitive impairment before intervention. The six-month cognitive preservation finding is reported without exaggeration. Loses points for not mentioning sample sizes or effect sizes, and for not acknowledging that amyloid clearance in mice has repeatedly failed to translate to humans (a well-documented problem in Alzheimer’s research that deserves mention).

Balance (7/10): The article is appropriately cautious about the mouse-to-human translation gap, explicitly stating more studies are needed. However, it presents amyloid plaques as a central driver of Alzheimer’s without acknowledging that this remains contested. The amyloid hypothesis has faced significant challenges in recent years.

Clarity (8/10): Well-structured and accessible. The “vacuum cleaner” analogy for phagocytosis is effective, and the explanation of astrocytes as overlooked support cells is clearly explained. The logical progression from problem to mechanism to result to implication is clean and easy to follow.

Overall (8/10): A quite rigorous piece, held back by omitting the broader debate around the amyloid hypothesis and the historical difficulty of translating mouse Alzheimer’s models to humans.